This paper is in the following e-collection/theme issue:

Innovative Methods in Public Health and Surveillance (383) JMIR Theme Issue: COVID-19 Special Issue (2554) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1542) Infectious Diseases (non-STD/STI) (1726) Public Health (247) Surveillance Systems (514)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/59274, first published .
Association Between Ursodeoxycholic Acid and Clinical Outcomes in Patients With COVID-19 Infection: Population-Based Cohort Study

Association Between Ursodeoxycholic Acid and Clinical Outcomes in Patients With COVID-19 Infection: Population-Based Cohort Study

Association Between Ursodeoxycholic Acid and Clinical Outcomes in Patients With COVID-19 Infection: Population-Based Cohort Study

Authors of this article:

Hyunjun Lee1 Author Orcid Image ;   Min Gul Kim2 Author Orcid Image ;   Sang Woo Yeom3 Author Orcid Image ;   Sang Jae Noh4 Author Orcid Image ;   Cho Yun Jeong3 Author Orcid Image ;   Min Ji Kim3 Author Orcid Image ;   Min Gu Kang3 Author Orcid Image ;   Ji Hoon Ko1 Author Orcid Image ;   Su Cheol Park1 Author Orcid Image ;   Hyeok Tae Kweon1 Author Orcid Image ;   Sang Il Sim5 Author Orcid Image ;   Hyun Lee6 Author Orcid Image ;   Yeon Seok You1 Author Orcid Image ;   Jong Seung Kim7 Author Orcid Image
Article Authors Cited by (2) Tweetations Metrics

Journals

  1. Okushin K, Ikeuchi K, Saito M, Kishida T, Kado A, Fujishiro M, Moriya K, Yotsuyanagi H, Koike K, Tsutsumi T. Use of Ursodeoxycholic Acid and the Risk of Severe Coronavirus Disease 2019 in Elderly Patients with Viral Hepatitis. Internal Medicine 2025;64(15):2301 View
  2. Park S, Moon E. Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2. Biomolecules & Therapeutics 2025;33(6):1064 View